We are live on ! Find out more
KALA icon

KALA BIO
KALA

26 hedge funds and large institutions have $24M invested in KALA BIO in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

99% more capital invested

Capital invested by funds: $12.1M → $24M (+$11.9M)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

18% more funds holding

Funds holding: 22 → 26 (+4)

0.58% more ownership

Funds ownership: 0.92% → 1.5% (+0.58%)

Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$3.8M
2
BBA
Baker Bros. Advisors
New York
+$1.96M
3
SCM
Silverarc Capital Management
Massachusetts
+$1.46M
4
SOCM
SR One Capital Management
Pennsylvania
+$979K
5
ACM
AIGH Capital Management
Maryland
+$765K

Top Sellers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
-$540K
2
Renaissance Technologies
Renaissance Technologies
New York
-$122K
3
Millennium Management
Millennium Management
New York
-$29.6K
4
Two Sigma Investments
Two Sigma Investments
New York
-$13.2K
5
Morgan Stanley
Morgan Stanley
New York
-$315
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$8.34M +$1.96M +6,211 +35%
CAM
2
Cormorant Asset Management
Massachusetts
$4.19M +$3.8M +12,061 New
SOCM
3
SR One Capital Management
Pennsylvania
$4.16M +$979K +3,106 +35%
SCM
4
Silverarc Capital Management
Massachusetts
$1.6M +$1.46M +4,621 New
ACM
5
ADAR1 Capital Management
Texas
$1.53M -$540K -1,714 -28%
UOC
6
UBS O'Connor
Illinois
$1.24M +$103K +326 +10%
Millennium Management
7
Millennium Management
New York
$944K -$29.6K -94 -3%
ACM
8
AIGH Capital Management
Maryland
$842K +$765K +2,426 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$372K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$331K +$66.5K +211 +28%
BlackRock
11
BlackRock
New York
$148K – – –
BOTOTLSJU
12
Board of Trustees of The Leland Stanford Junior University
California
$147K – – –
Two Sigma Investments
13
Two Sigma Investments
New York
$82.4K -$13.2K -42 -15%
Citigroup
14
Citigroup
New York
$39.4K +$34K +108 +1,800%
UBS Group
15
UBS Group
Switzerland
$21.9K +$19.5K +62 +6,200%
C
16
Covestor
United Kingdom
$7K – – –
Morgan Stanley
17
Morgan Stanley
New York
$6.75K -$315 -1 -5%
TRCT
18
Tower Research Capital (TRC)
New York
$4.94K -$315 -1 -7%
CLOS
19
Compagnie Lombard Odier SCmA
Switzerland
$2.78K – – –
MCM
20
MAI Capital Management
Ohio
$2.08K +$1.89K +6 New
Carson Wealth (CWM LLC)
21
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
SPIA
22
Steward Partners Investment Advisory
New York
$833 – – –
Osaic Holdings
23
Osaic Holdings
Arizona
$694 – – –
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$680 +$630 +2 New
JP Morgan Chase
25
JP Morgan Chase
New York
$416 – – –
1
2

KALA Hedge Fund Activity: Q4 2024 in Review

26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2024, worth a combined $24M — up 99% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new KALA positions and 1 closed out — a net gain of 4 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $3.8M. The largest seller was ADAR1 Capital Management, cutting an estimated $540K.

  • 26 institutional investors held KALA BIO (KALA) as of Q4 2024, up from 22 in Q3 2024.
  • Funds reported $24M of KALA BIO stock for Q4 2024, up 99% quarter-over-quarter.
  • 5 funds opened new KALA BIO positions in Q4 2024 and 1 closed out, a net change of +4 holders.
  • The largest KALA BIO buyer in Q4 2024 was Cormorant Asset Management, an estimated $3.8M added.
  • The largest KALA BIO seller in Q4 2024 was ADAR1 Capital Management, an estimated $540K sold.

Based on aggregated 13F filings for Q4 2024.